Tomotaka Shingaki
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial.
Journal: Current medical research and opinion
Published: July 11, 2026
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims database.
Journal: Journal of medical economics
Published: April 28, 2026
Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.
Journal: Diabetes, obesity & metabolism
Published: February 25, 2026
Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.
Journal: Advances in therapy
Published: November 18, 2025
Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.
Journal: Diabetes, obesity & metabolism
Published: August 19, 2025
Real-World Weight Loss Outcomes by Obesity Management Approaches in Japan: Descriptive Findings from the J-ORBIT Database Linked to Electronic Medical Records (J-ORBIT2).
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 30, 2025
Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT-1 Trial.
Journal: Obesity (Silver Spring, Md.)
Published: June 15, 2025
Real-world cross-sectional study evaluating patient characteristics, disease burden, and treatment approaches in people with obesity disease in Japan.
Journal: Current medical research and opinion
Published: March 31, 2025
Clinical and Humanistic Burden of Adult Obesity in Asia-Pacific: A Systematic Literature Review.
Journal: Advances in therapy
Published: March 17, 2025
Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial.
Journal: Diabetes, obesity & metabolism
Published: February 25, 2025
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The lancet. Diabetes & endocrinology
Published: September 29, 2024
Key factors for overcoming psychological insulin resistance: A qualitative study in Japanese people with type 2 diabetes.
Journal: Primary care diabetes
Published: February 24, 2021
Last Updated: 09/26/2026